
Wise Therapeutics
Creates science-based interventions in mental health.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
$530k | Seed | ||
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | - | 29 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Wise Therapeutics, now known as Arcade Therapeutics, was founded in 2018 by Dr. Tracy Dennis-Tiwary and Raj Amin. The company is headquartered in New York, USA.
Dr. Dennis-Tiwary, a professor of psychology and neuroscience, and Amin, with his background in digital health and mobile technology, combined their expertise to address the growing mental health crisis. Their goal was to create accessible and engaging digital solutions for mental wellness, backed by scientific research.
Wise Therapeutics develops and commercializes digital therapeutics in the form of mobile games. These games are designed to reduce stress and anxiety and are based on clinically validated research. The company's business model revolves around creating a pipeline of these game-based therapies, which they plan to get cleared by the FDA. This would allow the games to be prescribed by healthcare professionals, making them a part of mainstream mental health treatment. The company serves individuals seeking mental health support and aims to partner with healthcare providers and institutions.
One of their key products is "Personal Zen," an app that uses a game-based approach to help users build resilience against stress and anxiety. The app is designed to be used for just a few minutes each day and has been the subject of several clinical studies to validate its effectiveness.
Keywords: digital therapeutics, mental health, mobile games, anxiety reduction, stress management, FDA clearance, behavioral health, digital health, neuroscience, clinical research